TCHP vs. TMED

Last updated Jun 25, 2026

TCHP (T. Rowe Price Blue Chip Growth ETF) and TMED (T. Rowe Price Health Care ETF) are both exchange-traded funds - TCHP is a Large Cap Growth Equities fund actively managed by T. Rowe Price, while TMED is a Health & Biotech Equities fund managed by T. Rowe Price. Over the past year, TCHP returned 10.84% vs 33.64% for TMED. At a 0.30 correlation, their price movements are largely independent. TCHP charges 0.57%/yr vs 0.44%/yr for TMED.

Performance

TCHP vs. TMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Blue Chip Growth ETF (TCHP) and T. Rowe Price Health Care ETF (TMED). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TCHP achieves a -1.95% return, which is significantly lower than TMED's 10.47% return.

TCHP

• 1D: -0.22%
• 1M: -5.29%
• YTD: -1.95%
• 6M: -3.17%
• 1Y: 10.84%
• 3Y*: 21.33%
• 5Y*: 9.21%
• 10Y*: —

TMED

• 1D: 1.71%
• 1M: 5.92%
• YTD: 10.47%
• 6M: 9.58%
• 1Y: 33.64%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TCHP vs. TMED - Yearly Performance Comparison

	2026 (YTD)	2025
TCHP T. Rowe Price Blue Chip Growth ETF	-1.95%	14.07%
TMED T. Rowe Price Health Care ETF	10.47%	19.49%

Correlation

The correlation between TCHP and TMED is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.29
Correlation (All Time) Calculated using the full available price history since Jun 12, 2025	0.30

Return for Risk

TCHP vs. TMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TCHP

TCHP Risk / Return Rank: 19
TCHP Sharpe Ratio Rank: 20
TCHP Sortino Ratio Rank: 19
TCHP Omega Ratio Rank: 18
TCHP Calmar Ratio Rank: 17
TCHP Martin Ratio Rank: 19

TMED

TMED Risk / Return Rank: 66
TMED Sharpe Ratio Rank: 66
TMED Sortino Ratio Rank: 69
TMED Omega Ratio Rank: 61
TMED Calmar Ratio Rank: 70
TMED Martin Ratio Rank: 64

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TCHP vs. TMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Blue Chip Growth ETF (TCHP) and T. Rowe Price Health Care ETF (TMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TCHP	TMED	Difference
Sharpe ratio: Return per unit of total volatility	0.64	1.86	-1.22
Sortino ratio: Return per unit of downside risk	0.97	2.72	-1.75
Omega ratio: Gain probability vs. loss probability	1.12	1.32	-0.20
Calmar ratio: Return relative to maximum drawdown	0.62	3.04	-2.42
Martin ratio: Return relative to average drawdown	2.01	9.95	-7.94

TCHP vs. TMED - Sharpe Ratio Comparison

The current TCHP Sharpe Ratio is 0.64, which is lower than the TMED Sharpe Ratio of 1.86. The chart below compares the historical Sharpe Ratios of TCHP and TMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TCHP vs. TMED - Drawdown Comparison

The maximum TCHP drawdown since its inception was -42.34%, which is greater than TMED's maximum drawdown of -11.11%. Use the drawdown chart below to compare losses from any high point for TCHP and TMED.

Drawdown Indicators

	TCHP	TMED	Difference
Max Drawdown Largest peak-to-trough decline	-42.34%	-11.11%	-31.23%
Max Drawdown (1Y) Largest decline over 1 year	-17.50%	-11.11%	-6.39%
Max Drawdown (3Y) Largest decline over 3 years	-22.92%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-42.34%	—	—
Current Drawdown Current decline from peak	-7.79%	0.00%	-7.79%
Average Drawdown Average peak-to-trough decline	-11.40%	-2.47%	-8.93%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.40%	3.39%	+2.01%

Volatility

TCHP vs. TMED - Volatility Comparison

T. Rowe Price Blue Chip Growth ETF (TCHP) has a higher volatility of 6.74% compared to T. Rowe Price Health Care ETF (TMED) at 6.00%. This indicates that TCHP's price experiences larger fluctuations and is considered to be riskier than TMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TCHP	TMED	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.74%	6.00%	+0.74%
Volatility (6M) Calculated over the trailing 6-month period	13.38%	13.61%	-0.23%
Volatility (1Y) Calculated over the trailing 1-year period	17.13%	18.21%	-1.08%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.58%	18.08%	+5.50%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.21%	18.08%	+5.13%

TCHP vs. TMED - Expense Ratio Comparison

TCHP has a 0.57% expense ratio, which is higher than TMED's 0.44% expense ratio.

Dividends

TCHP vs. TMED - Dividend Comparison

TCHP has not paid dividends to shareholders, while TMED's dividend yield for the trailing twelve months is around 0.49%.

Position	TTM	2025	2024	2023	2022	2021
TCHP T. Rowe Price Blue Chip Growth ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.02%
TMED T. Rowe Price Health Care ETF	0.49%	0.54%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both TCHP and TMED in my portfolio?

TCHP and TMED have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TCHP or TMED?

TCHP has higher volatility (6.74%) compared to TMED (6.00%). In terms of maximum drawdown, TCHP dropped -42.34% vs TMED's -11.11%.

Which ETF is better, TCHP or TMED?

On 1-year performance, TMED leads with 33.64% vs 10.84% for TCHP. On fees, TMED is cheaper at 0.44% per year. On volatility, TMED has been the lower-risk option at 6.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, TCHP or TMED?

Over the 1-year period, TMED has performed better with a 33.64% return vs 10.84%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, TCHP or TMED?

TMED is cheaper with a 0.44% expense ratio, compared with 0.57% for TCHP.

Which ETF pays a higher dividend yield, TCHP or TMED?

TMED has the higher dividend yield at 0.49%, compared with 0.00% for TCHP.

What is the main difference between TCHP and TMED?

TCHP is categorized as Large Cap Growth Equities, while TMED is Health & Biotech Equities. Their fees differ too: 0.57% for TCHP and 0.44% for TMED.

Which has better risk-adjusted returns?

TMED currently has the higher Sharpe Ratio (1.86 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.